Menu
Back to Journals » Degenerative Neurological and Neuromuscular Disease » Volume 5
Detection of neuropathy using a sudomotor test in type 2 diabetes [Corrigendum]
Gandhi and Rao. Degener Neurol Neuromuscul Dis. 2015;5:1–7.
On page 2, the second sentence in the “SudoPath background” section is currently written: “The SudoPath is a patented system, and it uses the QSART method, by electrical stimulation of the postsympathetic cholinergic fibers and the switching of polarity, which induces microcirculation vasodilation and the release of chloride ions (Cl−) via the sweat ducts.”
It should have been: “SudoPath uses the quantitative sudomotor test method, by electrical stimulation of the postsympathetic cholinergic fibers and the switching of voltage polarity, which induces microcirculation vasodilation and the release of sweat.”
Read the original article
© 2015 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.